Roivant Sciences Company
Computational platform for drug discovery coupled with a technology-enabled "Vant" model to rapidly develop assets.
Investors
Connections from
Headquarters:
UK / USA
Employee Number:
501-1000
Industry:
End-to-End Drug Development
Total Funding:
> $6 B
Founded Date:
2014